News

Notification of a Potential Data Security Incident

Dear Madam/Sir: The Southern Illinois University School of Medicine, (“SIU”) is providing notice pursuant to 815 ILCS 530/25 in connection with an incident that may have involved the personal information of certain Illinois residents. This notice will be supplemented, if necessary, with any new significant facts discovered subsequent to its submission. While SIU is notifying you of this incident, SIU does not waive any rights or defenses relating to the incident or this notice. NATURE OF THE INCIDENT AND CORRECTIVE ACTIONS TAKEN SIU recently discovered that an unknown, unauthorized third party
News

Small dollars, big discoveries

Fall 2025 SIU Seed Grants have been awarded. These seed grants reflect SIU School of Medicine’s broader commitment to research that matters locally and resonates globally.
News

Small dollars, big discoveries

Fall 2025 SIU Seed Grants have been awarded. These seed grants reflect SIU School of Medicine’s broader commitment to research that matters locally and resonates globally.
News

Small dollars, big discoveries

Fall 2025 SIU Seed Grants have been awarded. These seed grants reflect SIU School of Medicine’s broader commitment to research that matters locally and resonates globally.
News

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.
News

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.
News

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.
News

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.
News

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.
Trial
Surgery

CLTI Biomarkers Supplement Study of the Esprit BTK Post-Approval Study

Active recruiting
The U.S. Food and Drug Administration (FDA) has recently approved the use of the Esprit BTK system for the treatment of narrowed arteries below the knee in patients with critical limb-threatening ischemia (CLTI). The purpose of this research study is to assess the continued safety and effectiveness of the Esprit BTK System. The purpose of the supplement study is to look at whether certain substances in the blood (called biomarkers) can help doctors predict the risk of blood clots or bleeding, understand the condition of the arteries now, and see how the artery health changes over time.
Subscribe to Research